Enact Holdings (ACT) director granted 162 deferred stock units via dividend reinvestment

Rhea-AI Filing Summary

Enact Holdings director John D. Fisk reported a routine compensation-related transaction involving deferred stock units. He acquired 162 deferred stock units as a grant or award, linked to a dividend reinvestment on March 19, 2026. These units correspond to 162 shares of common stock and were credited at a dividend rate of $0.21 per share. Following this transaction, Fisk directly holds a total of 30,705.457 deferred stock units. The footnotes state that these deferred stock units become payable in shares of common stock one year after his termination of service as a director.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FISK JOHN D

(Last) (First) (Middle)

C/O ENACT HOLDINGS, INC.

8325 SIX FORKS ROAD

(Street)

RALEIGH NORTH CAROLINA 27615

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enact Holdings, Inc. [ ACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	03/19/2026		A		162		(1)	(1)	Common Stock	162	$0(2)	30,705.457	D

Explanation of Responses:

1. Deferred Stock Units become payable in shares of Common Stock one year after termination of service as a director.

2. Additional deferred stock units acquired pursuant to reinvestment terms under the director award agreement from a dividend paid on March 19, 2026, at $0.21 per share.

Remarks:

	/s/ Joe Jacumin, by power of attorney	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Enact Holdings (ACT) director John D. Fisk report?

John D. Fisk reported acquiring 162 deferred stock units as a grant or award. These units are tied to Enact Holdings common stock and increase his total deferred stock unit holdings to 30,705.457 following the transaction.

How many Enact Holdings (ACT) deferred stock units does John D. Fisk now hold?

After the reported transaction, John D. Fisk directly holds 30,705.457 deferred stock units. This total reflects the addition of 162 units acquired through a grant or award connected to a March 19, 2026 dividend reinvestment.

What are the terms of Enact Holdings (ACT) deferred stock units reported by John D. Fisk?

The deferred stock units become payable in Enact Holdings common stock one year after termination of service as a director. This means Fisk receives actual shares only after leaving the board and waiting the specified one-year period.

How were the additional Enact Holdings (ACT) deferred stock units for John D. Fisk generated?

The additional 162 deferred stock units were acquired under dividend reinvestment terms in the director award agreement. They stem from a dividend paid on March 19, 2026 at a cash rate of $0.21 per share on the underlying stock.

Does the Enact Holdings (ACT) Form 4 show a market purchase or sale by John D. Fisk?

The Form 4 shows a grant or award acquisition of 162 deferred stock units, not an open-market purchase or sale. The transaction is compensation-related and arises from dividend reinvestment under the director award agreement.